UPDATED Jun 30, 2022
Popular and high growth companies which might be overvalued.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
300896Imeik Technology DevelopmentLtd | CN„590.96 | 4.8% | -25.1% | CN„129.8b | CN„654.22 | PE119.8x | E37.8% | 0.4% | ||
300759Pharmaron Beijing | CN„95.74 | 2.9% | -29.8% | CN„107.8b | CN„105.08 | PE68.5x | E27.9% | 0.3% | ||
688363Bloomage BioTechnology | CN„139.43 | 2.3% | -50.1% | CN„68.4b | CN„153.68 | PE80.8x | E28.5% | 0.4% | ||
603456Zhejiang Jiuzhou Pharmaceutical | CN„50.27 | -0.06% | 10.0% | CN„43.1b | CN„63.18 | PE56.1x | E29.7% | 0.5% | ||
300558Betta Pharmaceuticals | CN„55.69 | -9.7% | -46.3% | CN„25.3b | CN„85.80 | PE72.5x | E43.2% | 0.4% | ||
2653Haisco Pharmaceutical Group | CN„16.13 | 2.9% | -25.1% | CN„17.2b | n/a | PE204.5x | E84.3% | 1.1% | ||
300841Chengdu Kanghua Biological Products | CN„116.01 | 22.1% | -33.8% | CN„15.5b | CN„158.78 | PE18.1x | E27.8% | 0.9% | ||
603229Zhejiang Ausun Pharmaceutical | CN„39.02 | 14.7% | 75.0% | CN„15.3b | n/a | PE90.8x | E34.0% | 0.2% | ||
688131Shanghai Haoyuan Chemexpress | CN„139.99 | 1.3% | -39.2% | CN„14.8b | n/a | PE73.2x | E40.5% | 0.3% | ||
688356Jenkem Technology | CN„234.00 | 3.8% | -18.3% | CN„14.5b | n/a | PE73.1x | E27.7% | 0.4% | ||
301080AcrobiosystemsLtd | CN„166.01 | -4.6% | n/a | CN„13.4b | CN„184.98 | PE71x | E38.3% | 0.9% | ||
300685Amoy Diagnostics | CN„32.75 | 10.0% | -39.9% | CN„12.7b | CN„45.95 | PE52.2x | E27.4% | 0.4% | ||
688315Novogene | CN„24.85 | -6.6% | -45.1% | CN„10.3b | CN„28.89 | PE47.1x | E33.2% | 0.2% | ||
300653Yantai Zhenghai Biotechnology | CN„55.02 | -2.0% | 8.2% | CN„10.1b | n/a | PE55.1x | E25.1% | 1.1% | ||
688166BrightGene Bio-Medical Technology | CN„23.77 | -4.0% | -40.1% | CN„9.9b | n/a | PE38.1x | E31.9% | 0.5% | ||
300702Zhejiang Tianyu Pharmaceutical | CN„29.85 | 4.0% | -17.5% | CN„9.9b | CN„41.47 | PE66.6x | E40.8% | 0.3% | ||
603520Zhejiang Starry PharmaceuticalLtd | CN„28.13 | -3.5% | -34.9% | CN„9.6b | CN„35.71 | PE28.4x | E31.8% | 1.3% | ||
605116Aurisco PharmaceuticalLtd | CN„22.20 | 3.7% | 59.9% | CN„8.8b | n/a | PE52.8x | E25.7% | 0.5% | ||
688621Beijing Sun-Novo Pharmaceutical Research | CN„108.84 | 11.7% | 13.4% | CN„8.8b | CN„105.05 | PE73.5x | E33.1% | 0.2% | ||
301096Hangzhou Bio-Sincerity Pharma-TechLtd | CN„79.30 | 7.0% | n/a | CN„8.5b | n/a | PE67.9x | E43.5% | 0.8% | ||
VLAValneva | âŹ10.86 | -23.7% | -6.4% | âŹ1.2b | âŹ17.80 | PS3.4x | E80.5% | n/a | ||
VCELVericel | US$25.18 | -2.0% | -52.2% | US$1.2b | US$47.40 | PS7.5x | E89.6% | n/a | ||
300723ApicHope Pharmaceutical | CN„27.28 | -0.8% | -13.6% | CN„7.6b | n/a | PE24.3x | E25.3% | 0.7% | ||
300705Hunan Jiudian Pharmaceutical | CN„21.61 | 2.9% | -21.0% | CN„7.2b | CN„31.81 | PE33.2x | E29.5% | 0.9% |